Fujian Aonong Biological Technology Group Incorporation Limited, commonly referred to as Aonong, is a leading player in the biotechnology sector, headquartered in Fujian, China. Established in 2001, the company has made significant strides in the development of innovative biological products, primarily focusing on animal health and nutrition. Aonong's core offerings include high-quality probiotics, feed additives, and health supplements, which are distinguished by their advanced formulations and commitment to sustainability. With a strong presence in both domestic and international markets, Aonong has positioned itself as a trusted partner for livestock producers seeking to enhance animal welfare and productivity. Recognised for its research-driven approach, Aonong has achieved notable milestones, including various industry certifications and partnerships that underscore its commitment to quality and innovation in the biotechnology field.
How does Fujian Aonong Biological Technology Group Incorporation Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Food Product Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Fujian Aonong Biological Technology Group Incorporation Limited's score of 12 is lower than 70% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Fujian Aonong Biological Technology Group Incorporation Limited, headquartered in China, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Fujian Aonong may not have established formal commitments to reduce its carbon footprint or engage in industry-standard climate initiatives. As the company does not inherit emissions data from a parent organisation, it operates independently in terms of climate reporting. Without specific emissions figures or reduction initiatives, it is challenging to assess the company's environmental impact or commitment to sustainability within the broader context of the biotechnology industry.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Fujian Aonong Biological Technology Group Incorporation Limited has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
